Treant Zorggroep, location Bethesda
Hoogeveen, Netherlands
General hospital in Hoogeveen
Dr. G.H. Amshoffweg 1, 7909 AA Hoogeveen
About Treant Zorggroep, location Bethesda
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Diamyd Medical AB
1
Medtronic BRC
1
Clinical Trials at Treant Zorggroep, location Bethesda
During the past decade, Treant Zorggroep, location Bethesda conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
INSIGHT (R)XT. Indications for Diagnosis, Arrhythmia and Monitoring of Reveal XT
2008-04-01
2013-04-01
Completed
1,003
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Diamyd Administered Into Lymph Nodes in Individuals Recently Diagnosed With Type 1 Diabetes, Carrying the HLA DR3-DQ2 Haplotype
2022-05-19
2025-12-31
Recruiting
330
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Treant Zorggroep, location Bethesda
According to Clinical.Site data, the most researched conditions in "Treant Zorggroep, location Bethesda" are
"Cardiovascular Disease" (2 trials), "Atrial Fibrillation" (1 trials), "Autoimmune Diabetes" (1 trials), "Autoimmune Diseases" (1 trials) and "Cardiac Arrhythmias" (1 trials). Many other conditions were trialed in "Treant Zorggroep, location Bethesda" in a lesser frequency.
Clinical Trials Intervention Types at Treant Zorggroep, location Bethesda
Most popular intervention types in "Treant Zorggroep, location Bethesda" are "Drug" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Colecalciferol 2000 IU" (1 trials), "Placebo for recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®" (1 trials) and "Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Treant Zorggroep, location Bethesda
The vast majority of trials in "Treant Zorggroep, location Bethesda" are
4 trials for "All" genders.
Clinical Trials Status at Treant Zorggroep, location Bethesda
Currently, there are NaN active trials in "Treant Zorggroep, location Bethesda".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Treant Zorggroep, location Bethesda,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Treant Zorggroep, location Bethesda, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".